The recombinant lectin-like domain of thrombomodulin inhibits angiogenesis through interaction with Lewis Y antigen

被引:46
作者
Kuo, Cheng-Hsiang [1 ,2 ,3 ]
Chen, Po-Ku [1 ,2 ,3 ]
Chang, Bi-Ing [1 ,3 ]
Sung, Meng-Chen [1 ]
Shi, Chung-Sheng [1 ]
Lee, Jeng-Shin [4 ]
Chang, Chuan-Fa [3 ,5 ]
Shi, Guey-Yueh [1 ,3 ]
Wu, Hua-Lin [1 ,3 ,6 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 701, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 701, Taiwan
[3] Natl Cheng Kung Univ, Coll Med, Cardiovasc Res Ctr, Tainan 701, Taiwan
[4] Harvard Univ, Sch Med, Harvard Gene Therapy Initiat, Boston, MA USA
[5] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 701, Taiwan
[6] Natl Cheng Kung Univ, Ctr Biosci & Biotechnol, Tainan 701, Taiwan
关键词
SOLUBLE THROMBOMODULIN; PLASMA THROMBOMODULIN; MITOGENIC ACTIVITY; GROWTH; EXPRESSION; PROTEIN; METASTASIS; ADHESION; BINDING; INVOLVEMENT;
D O I
10.1182/blood-2011-08-376038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lewis YAg (LeY) is a cell-surface tetrasaccharide that participates in angiogenesis. Recently, we demonstrated that LeY is a specific ligand of the recombinant lectin-like domain of thrombomodulin (TM). However, the biologic function of interaction between LeY and TM in endothelial cells has never been investigated. Therefore, the role of LeY in tube formation and the role of the recombinant lectin-like domain of TM-TM domain 1 (rTMD1)-in antiangiogenesis were investigated. The recombinant TM ectodomain exhibited lower angiogenic activity than did the recombinant TM domains 2 and 3. rTMD1 interacted with soluble LeY and membrane-bound LeY and inhibited soluble LeY-mediated chemotaxis of endothelial cells. LeY was highly expressed on membrane ruffles and protrusions during tube formation on Matrigel. Blockade of LeY with rTMD1 or Ab against LeY inhibited endothelial tube formation in vitro. Epidermal growth factor (EGF) receptor in HU-VECs was LeY modified. rTMD1 inhibited EGF receptor signaling, chemotaxis, and tube formation in vitro, and EGF-mediated angiogenesis and tumor angiogenesis in vivo. We concluded that LeY is involved in vascular endothelial tube formation and rTMD1 inhibits angiogenesis via interaction with LeY. Administration of rTMD1 or recombinant adeno-associated virus vector carrying TMD1 could be a promising antiangiogenesis strategy. (Blood. 2012;119(5): 1302-1313)
引用
收藏
页码:1302 / 1313
页数:12
相关论文
共 48 条
[1]   The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism [J].
Abeyama, K ;
Stern, DM ;
Ito, Y ;
Kawahara, K ;
Yoshimoto, Y ;
Tanaka, M ;
Uchimura, T ;
Ida, N ;
Yamazaki, Y ;
Yamada, S ;
Yamamoto, Y ;
Yamamoto, H ;
Iino, S ;
Taniguchi, N ;
Maruyama, I .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (05) :1267-1274
[2]   MODULATION OF EGF BINDING AND ACTION BY SUCCINYLATED CONCANAVALIN-A IN FIBROBLAST CELL-CULTURES [J].
BALLMER, K ;
BURGER, MM .
JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1980, 14 (02) :209-214
[3]  
BASU A, 1987, CANCER RES, V47, P2531
[4]   Tumorigenesis and the angiogenic switch [J].
Bergers, G ;
Benjamin, LE .
NATURE REVIEWS CANCER, 2003, 3 (06) :401-410
[5]   PRESERVATION OF THROMBOMODULIN ANTIGEN ON VASCULAR AND EXTRAVASCULAR SURFACES [J].
BOFFA, MC ;
BURKE, B ;
HAUDENSCHILD, CC .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1987, 35 (11) :1267-1276
[6]   Angiogenesis in life, disease and medicine [J].
Carmeliet, P .
NATURE, 2005, 438 (7070) :932-936
[7]   Increasing post-event plasma thrombomodulin level associates with worse outcome in survival of acute coronary syndrome [J].
Chan, Shih-Hung ;
Chen, Jyh-Hong ;
Li, Yi-Heng ;
Lin, Li-Jen ;
Tsai, Liang-Miin .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 111 (02) :280-285
[8]   The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor κB and mitogen-activated protein kinase pathways [J].
Conway, EM ;
Van de Wouwer, M ;
Pollefeyt, S ;
Jurk, K ;
Van Aken, H ;
De Vriese, A ;
Weitz, JI ;
Weiler, H ;
Hellings, PW ;
Schaeffer, P ;
Herbert, JM ;
Collen, D ;
Theilmeier, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (05) :565-577
[9]   Inhibition of xenograft tumor growth and down-regulation of ErbB receptors by an antibody directed against Lewis Y antigen [J].
Farhan, Hesso ;
Schuster, Christian ;
Klinger, Markus ;
Weisz, Eva ;
Waxenecker, Guenter ;
Schuster, Manfred ;
Sexl, Veronika ;
Mudde, Geert C. ;
Freissmuth, Michael ;
Kircheis, Ralf .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (03) :1459-1466
[10]  
FOURNIER GA, 1981, INVEST OPHTH VIS SCI, V21, P351